You have 9 free searches left this month | for more free features.

City

Nijmegen (2)

Condition

Coronary Artery Bypass Grafting (1)

Endotoxemia (1)

Systemic Inflammatory Response (1)

Systemic Inflammatory Response Syndrome (1)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Radboud University Medical Center (2)

Collaborator

Exponential Biotherapies Inc. (2)

Intervention

ea-230 (2)

endotoxin (1)

placebo (1)

placebo (nacl) (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

ea-230

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Systemic Inflammatory Response Syndrome, Coronary Artery Bypass Grafting Trial in Nijmegen (EA-230, Placebo (NaCl))

Unknown status

Systemic Inflammatory Response Syndrome
Coronary Artery Bypass Grafting

EA-230
Placebo (NaCl)

Nijmegen, Gelderland, Netherlands

Intensive care, research unit, Radboud University Medical Centre

Jun 25, 2018

Endotoxemia, Systemic Inflammatory Response Trial in Nijmegen (EA-230, Endotoxin, Placebo)

Completed

Endotoxemia
Systemic Inflammatory Response

EA-230
+2 more

Nijmegen, Gelderland, Netherlands

Intensive care, research unit, Radboud University Medical Centre

Jun 22, 2016